المؤلفون: Manchikalapati R, Schening J; Division of Pulmonology, Section of Allergy-Immunology, Phoenix Children's Hospital, Phoenix, Arizona., Farias AJ; Division of Critical Care, Phoenix Children's Hospital, Phoenix, Arizona., Sacco KA

المصدر: Shock (Augusta, Ga.) [Shock] 2024 Mar 01; Vol. 61 (3), pp. 340-345. Date of Electronic Publication: 2023 Sep 05.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9421564 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-0514 (Electronic) Linking ISSN: 10732322 NLM ISO Abbreviation: Shock Subsets: MEDLINE

مواضيع طبية MeSH: Interleukin 1 Receptor Antagonist Protein*/therapeutic use , Sepsis*/drug therapy, Adult ; Child ; Humans ; Ferritins ; Interleukin Inhibitors ; Interleukin-1 ; Retrospective Studies

المؤلفون: Parry-Jones AR; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance & University of Manchester, Manchester, UK.; Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Stocking K; Centre for Biostatistics, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., MacLeod MJ; The Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK., Clarke B; Department of Stroke Medicine, St George's University Hospitals NHS Foundation Trust, London, UK., Werring DJ; Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, London, UK., Muir KW; School of Psychology and Neuroscience, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Vail A; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance & University of Manchester, Manchester, UK.; Centre for Biostatistics, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

المصدر: European stroke journal [Eur Stroke J] 2023 Sep; Vol. 8 (3), pp. 819-827. Date of Electronic Publication: 2023 Jul 15.

نوع المنشور: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: SAGE Publications Ltd Country of Publication: England NLM ID: 101688446 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2396-9881 (Electronic) Linking ISSN: 23969873 NLM ISO Abbreviation: Eur Stroke J Subsets: MEDLINE

مواضيع طبية MeSH: Interleukin 1 Receptor Antagonist Protein*/adverse effects , Cytokines*/therapeutic use, Humans ; Male ; Aged ; Female ; Interleukin-6/therapeutic use ; Cerebral Hemorrhage/drug therapy ; Interleukin Inhibitors ; Receptors, Interleukin-1 ; Interleukin-1

المؤلفون: Liu XH; Department of Cardiology, Yichang Hospital of Traditional Chinese Medicine, Yichang 443000, China; Three Gorges University Hospital of Traditional Chinese Medicine, Three Gorges University, Yichang 443000, China., Zhang L; Department of Cardiology, Yichang Hospital of Traditional Chinese Medicine, Yichang 443000, China; Three Gorges University Hospital of Traditional Chinese Medicine, Three Gorges University, Yichang 443000, China. Electronic address: yczyyzl@sina.com.

المصدر: International journal of cardiology [Int J Cardiol] 2024 Sep 15; Vol. 411, pp. 132297. Date of Electronic Publication: 2024 Jun 25.

نوع المنشور: Letter

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8200291 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1874-1754 (Electronic) Linking ISSN: 01675273 NLM ISO Abbreviation: Int J Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Interleukin 1 Receptor Antagonist Protein*/therapeutic use , Interleukin 1 Receptor Antagonist Protein*/administration & dosage , ST Elevation Myocardial Infarction*/drug therapy, Humans ; Male ; Female ; Middle Aged ; Aged ; Antirheumatic Agents/therapeutic use ; Antirheumatic Agents/administration & dosage

المؤلفون: Rane SS; Manchester Academic Health Science Centre, Faculty of Biology Medicine and Health, School of Biological Sciences, The University of Manchester, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Shellard E; Manchester Academic Health Science Centre, Faculty of Biology Medicine and Health, School of Biological Sciences, The University of Manchester, Manchester, UK., Adamson A; Manchester Academic Health Science Centre, Faculty of Biology Medicine and Health, School of Biological Sciences, The University of Manchester, Manchester, UK., Eyre S; Manchester Academic Health Science Centre, Faculty of Biology Medicine and Health, School of Biological Sciences, The University of Manchester, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Warren RB; Manchester Academic Health Science Centre, Faculty of Biology Medicine and Health, School of Biological Sciences, The University of Manchester, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.; Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, UK.

المصدر: Experimental dermatology [Exp Dermatol] 2024 Sep; Vol. 33 (9), pp. e15180.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Munksgaard Country of Publication: Denmark NLM ID: 9301549 Publication Model: Print Cited Medium: Internet ISSN: 1600-0625 (Electronic) Linking ISSN: 09066705 NLM ISO Abbreviation: Exp Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Psoriasis*/genetics , Receptors, Interleukin*/genetics , Receptors, Interleukin*/metabolism , STAT3 Transcription Factor*/genetics , STAT3 Transcription Factor*/metabolism, Humans ; Jurkat Cells ; Mutation ; CD4-Positive T-Lymphocytes/metabolism ; CD8-Positive T-Lymphocytes ; Gene Expression Regulation ; Suppressor of Cytokine Signaling 1 Protein/genetics ; Suppressor of Cytokine Signaling 1 Protein/metabolism ; Phosphorylation ; Signal Transduction/genetics ; Genetic Predisposition to Disease ; Receptors, CXCR3/genetics ; Receptors, CXCR3/metabolism

المؤلفون: Masuyuki R; Department of Dermatology, Fukuoka University Faculty of Medicine, Fukuoka, Japan., Sato E; Department of Dermatology, Fukuoka University Faculty of Medicine, Fukuoka, Japan., Imafuku S; Department of Dermatology, Fukuoka University Faculty of Medicine, Fukuoka, Japan.

المصدر: The Journal of dermatology [J Dermatol] 2024 Sep; Vol. 51 (9), pp. 1252-1255. Date of Electronic Publication: 2024 Mar 20.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1346-8138 (Electronic) Linking ISSN: 03852407 NLM ISO Abbreviation: J Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Pemphigoid, Bullous*/chemically induced , Pemphigoid, Bullous*/immunology , Pemphigoid, Bullous*/diagnosis , Pemphigoid, Bullous*/drug therapy , Antibodies, Monoclonal, Humanized*/adverse effects , Receptors, Interleukin*/antagonists & inhibitors , Receptors, Interleukin*/immunology, Humans ; Male ; Middle Aged ; Dermatitis, Atopic/drug therapy ; Dermatitis, Atopic/immunology ; Dermatitis, Atopic/chemically induced ; Non-Fibrillar Collagens/immunology ; Collagen Type XVII ; Prurigo/immunology ; Prurigo/chemically induced ; Prurigo/drug therapy ; Prurigo/diagnosis ; Prurigo/pathology ; Autoantigens/immunology ; Prednisolone/therapeutic use ; Autoantibodies/blood ; Autoantibodies/immunology ; Skin/pathology ; Skin/drug effects ; Cyclosporine/adverse effects ; Cyclosporine/therapeutic use

المؤلفون: Polgreen LE; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA. lpolgreen@lundquist.org.; Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. lpolgreen@lundquist.org., Chen AH; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.; Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Pak Y; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.; Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Luzzi A; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA., Morales Garval A; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA., Acevedo J; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA., Bitan G; Department of Neurology, David Geffen School of Medicine, Brain Research Institute and Molecular Biology Institute University of California, Los Angeles, Los Angeles, CA, USA., Iacovino M; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.; Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., O'Neill C; Cure Sanfilippo Foundation, Columbia, SC, USA., Eisengart JB; Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN, USA.

المصدر: Nature medicine [Nat Med] 2024 Sep; Vol. 30 (9), pp. 2473-2479. Date of Electronic Publication: 2024 Jun 21.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Clinical Trial, Phase I

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Interleukin 1 Receptor Antagonist Protein*/therapeutic use , Interleukin 1 Receptor Antagonist Protein*/adverse effects , Mucopolysaccharidosis III*/drug therapy , Mucopolysaccharidosis III*/pathology, Humans ; Child ; Adolescent ; Male ; Adult ; Female ; Young Adult ; Quality of Life ; Treatment Outcome

المؤلفون: Liu YN; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Liu MK; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Wen YC; Department of Urology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; TMU Research Center of Urology and Kidney, Taipei Medical University, Taipei, Taiwan., Li CH; Department of Urology, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan., Yeh HL; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Dung PVT; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Jiang KC; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Chen WH; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Li HR; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Huang J; Department of Pathology, Duke University Medical Center, Durham, NC, USA., Chen WY; Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. Electronic address: 1047@tmu.edu.tw.

المصدر: Cancer letters [Cancer Lett] 2024 Aug 28; Vol. 598, pp. 217090. Date of Electronic Publication: 2024 Jun 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Microenvironment* , Interleukin 1 Receptor Antagonist Protein*/pharmacology , Interleukin 1 Receptor Antagonist Protein*/metabolism , Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/drug therapy , Prostatic Neoplasms*/immunology , Prostatic Neoplasms*/metabolism , Cell Differentiation*/drug effects, Male ; Humans ; Cell Line, Tumor ; Signal Transduction/drug effects ; Animals ; Androgen Antagonists/pharmacology ; Androgen Antagonists/therapeutic use ; Macrophages/metabolism ; Macrophages/immunology ; E2F1 Transcription Factor/metabolism ; E2F1 Transcription Factor/genetics

المؤلفون: Dong W; Department of Orthopaedic Surgery and Biomedical Engineering, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.; Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, 150001, Heilongjiang, People's Republic of China., Tian C; Saint Jude Children's Research Hospital, Memphis, TN, USA., Li ZG; Department of Orthopaedic Surgery and Biomedical Engineering, University of Tennessee Health Science Center, Memphis, TN, 38163, USA., Bounds M; Department of Orthopaedic Surgery and Biomedical Engineering, University of Tennessee Health Science Center, Memphis, TN, 38163, USA., Ma J; Department of Orthopaedic Surgery and Biomedical Engineering, University of Tennessee Health Science Center, Memphis, TN, 38163, USA., Brand DD; Lt. Col. Luke Weathers, Jr. VA Medical Center, 116 N Pauline St., Memphis, TN, 38105, USA.; Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, 38163, USA., Liu X; Center for Clinical Precision Medication, The First Affiliated Hospital, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China.; Clinical Pharmacy (School of Integrative Pharmacy, Institute of Integrative Pharmaceutical Research), Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China., Cao Y; Institute of Kaschin-Beck Disease, Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Key Laboratory of Etiologic Epidemiology, Education Bureau of Heilongjiang Province and Ministry of Health (23618104), Harbin Medical University, Harbin, 150081, People's Republic of China., Beard A; Department of Orthopaedic Surgery and Biomedical Engineering, University of Tennessee Health Science Center, Memphis, TN, 38163, USA., Yan J; Department of Orthopaedic Surgery and Biomedical Engineering, University of Tennessee Health Science Center, Memphis, TN, 38163, USA., Hasty K; Department of Orthopaedic Surgery and Biomedical Engineering, University of Tennessee Health Science Center, Memphis, TN, 38163, USA., Stuart J; Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, 38163, USA., Li K; Department of Microbiology, Immunology, and Biochemistry, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, 38163, USA., Cho H; Department of Orthopaedic Surgery and Biomedical Engineering, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.; Lt. Col. Luke Weathers, Jr. VA Medical Center, 116 N Pauline St., Memphis, TN, 38105, USA., Fitzpatrick EA; Department of Microbiology, Immunology, and Biochemistry, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, 38163, USA., Myers LK; Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, 38163, USA., Jiao Y; Department of Orthopaedic Surgery and Biomedical Engineering, University of Tennessee Health Science Center, Memphis, TN, 38163, USA. yjiao2@utshc.edu., Gu W; Department of Orthopaedic Surgery and Biomedical Engineering, University of Tennessee Health Science Center, Memphis, TN, 38163, USA. wgu@uthsc.edu.; Lt. Col. Luke Weathers, Jr. VA Medical Center, 116 N Pauline St., Memphis, TN, 38105, USA. wgu@uthsc.edu.

المصدر: Scientific reports [Sci Rep] 2024 Aug 27; Vol. 14 (1), pp. 19889. Date of Electronic Publication: 2024 Aug 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Bone Density*/genetics , Interleukin 1 Receptor Antagonist Protein*/genetics , Interleukin 1 Receptor Antagonist Protein*/deficiency , Quantitative Trait Loci* , Mice, Knockout*, Animals ; Mice ; Mice, Inbred BALB C ; Bone and Bones/metabolism ; Bone and Bones/diagnostic imaging ; Bone and Bones/pathology ; Mice, Inbred DBA ; Male ; Phenotype ; X-Ray Microtomography ; Hereditary Autoinflammatory Diseases

SCR Disease Name: Deficiency of interleukin-1 receptor antagonist

المؤلفون: Forgerini M; Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista 'Júlio de Mesquita Filho', Araraquara, SP, Brazil., Zanelli CF; Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista 'Júlio de Mesquita Filho', Araraquara, SP, Brazil., Valentini SR; Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista 'Júlio de Mesquita Filho', Araraquara, SP, Brazil., Mastroianni PC; Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista 'Júlio de Mesquita Filho', Araraquara, SP, Brazil.

المصدر: Einstein (Sao Paulo, Brazil) [Einstein (Sao Paulo)] 2024 Aug 26; Vol. 22, pp. eAO0746. Date of Electronic Publication: 2024 Aug 26 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Instituto de Ensino e Pesquisa Albert Einstein Country of Publication: Brazil NLM ID: 101281800 Publication Model: eCollection Cited Medium: Internet ISSN: 2317-6385 (Electronic) Linking ISSN: 16794508 NLM ISO Abbreviation: Einstein (Sao Paulo) Subsets: MEDLINE

مواضيع طبية MeSH: Aspirin*/adverse effects , Tumor Necrosis Factor-alpha*/genetics , Interleukin-1beta*/genetics , Gastrointestinal Hemorrhage*/chemically induced , Gastrointestinal Hemorrhage*/genetics , Interleukin 1 Receptor Antagonist Protein*/genetics , Interleukin 1 Receptor Antagonist Protein*/adverse effects, Humans ; Male ; Case-Control Studies ; Female ; Middle Aged ; Aged ; Risk Factors ; Genotype ; Genetic Predisposition to Disease/genetics ; Adult ; Polymorphism, Single Nucleotide

المؤلفون: Wang R; Department of Pulmonary and Critical Care Medicine, Shanxi Bethune Hospital,Shanxi Academy of Medical Sciences,Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, China; Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Taiyuan, Shanxi, China. Electronic address: wry0526@163.com., Zhu Z; Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Taiyuan, Shanxi, China., Peng S; Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Taiyuan, Shanxi, China., Xu J; Department of Pulmonary and Critical Care Medicine, Shanxi Bethune Hospital,Shanxi Academy of Medical Sciences,Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, China., Chen Y; Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, China., Wei S; Department of Pulmonary and Critical Care Medicine, Shanxi Bethune Hospital,Shanxi Academy of Medical Sciences,Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, China; Department of Pulmonary and Critical Care Medicine,Tongji Hospital,Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China., Liu X; Department of Pulmonary and Critical Care Medicine, Shanxi Bethune Hospital,Shanxi Academy of Medical Sciences,Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, China; Department of Pulmonary and Critical Care Medicine,Tongji Hospital,Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Electronic address: doctorliu69@126.com.

المصدر: International immunopharmacology [Int Immunopharmacol] 2024 Aug 20; Vol. 137, pp. 112466. Date of Electronic Publication: 2024 Jun 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Exosomes*/metabolism , Interleukin 1 Receptor Antagonist Protein*/metabolism , Interleukin 1 Receptor Antagonist Protein*/genetics , Macrophages*/immunology , Macrophages*/metabolism , MicroRNAs*/metabolism , MicroRNAs*/genetics , Pulmonary Disease, Chronic Obstructive*/metabolism , Pulmonary Disease, Chronic Obstructive*/immunology, Animals ; Humans ; Male ; Mice ; Epithelial Cells/metabolism ; Macrophage Activation ; Mice, Inbred C57BL ; Respiratory Mucosa/metabolism ; Respiratory Mucosa/immunology ; Respiratory Mucosa/pathology ; THP-1 Cells